Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' WERDAN K' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 93 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Werner, C; Werdan, K; Ponicke, K; Brodde, OE
      Impaired beta-adrenergic control of immune function in patients with chronic heart failure: reversal by beta(1)-blocker treatment

      BASIC RESEARCH IN CARDIOLOGY
    2. Schmidt, HB; Rauchhaus, M; Francis, DP; Davis, CL; Nuding, S; Peschel, T; Schmidt, DS; Coats, AJS; Opitz, H; Werdan, K
      Assessment of chemoreflex sensitivity in free breathing young subjects by correction for respiratory influence

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    3. Buchhorn, R; Wessel, A; Hulpke-Wette, M; Bursch, J; Werdan, K; Loppnow, H
      Endogenous nitric oxide and soluble tumor necrosis factor receptor levels are enhanced in infants with congenital heart disease

      CRITICAL CARE MEDICINE
    4. Lindner, A; Panzner, B; Werdan, K; Zierz, S
      Cerebral ischemic insult - Etiology, therapy, prophylaxis

      INTERNIST
    5. Soeffker, G; Schmidt, HB; Rainov, NG; Werdan, K
      Intractable angina in end-stage coronary artery disease - Neuromodulation as an opportunity?

      INTERNIST
    6. Werdan, K; Endres, S
      Cytokines and anti-cytokine therapies

      INTERNIST
    7. Kuhn, C; Muller-Werdan, U; Schmitt, DV; Lange, H; Pilz, G; Kreuzer, E; Mohr, FW; Zerkowski, HR; Werdan, K
      Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988-1990: the ESSICS-study pilot project

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    8. Muller-Werdan, U; Werdan, K
      Immune modulation by catecholamines - a potential mechanism of cytokine release in heart failure?

      HERZ
    9. Georgiadis, D; Sievert, M; Cencetti, S; Uhlmann, F; Krivokuca, M; Zierz, S; Werdan, K
      Cerebrovascular reactivity is impaired in patients with cardiac failure

      EUROPEAN HEART JOURNAL
    10. Jager, D; Seliger, C; Redpath, NT; Friedrich, I; Silber, RE; Ponicke, K; Werdan, K; Muller-Werdan, U
      Heterogeneity of cardiac rat and human elongation factor 2

      ELECTROPHORESIS
    11. Thiemermann, C; Werdan, K; Meier-Hellmann, A; Spies, C; Radermacher, P; Briegel, J
      The use of haemodynamically active substances in sepsis and multi-organ dysfunction syndrome (MODS)

      ANASTHESIOLOGIE & INTENSIVMEDIZIN
    12. Muller-Werdan, U; Werdan, K
      Anaphylactic shock

      WIENER KLINISCHE WOCHENSCHRIFT
    13. Krivokuca, M; Werdan, K
      Treatment of acute heart failure - Emergency therapy - Comment

      INTERNIST
    14. Muller-Werdan, U; Werdan, K
      Anaphylaxis and allergy - Recommendations for emergency therapy

      INTERNIST
    15. Krivokuca, M; Werdan, K
      Treatment of acute heart failure - Emergency therapy

      INTERNIST
    16. Schuster, HP; Werdan, K
      Intensive care medicine - Proven and new concepts put to the test

      INTERNIST
    17. Heinroth, KM; Werdan, K
      Temporary cardiac pacing - Tranvenous, transcutaneous or transgastric?

      INTERNIST
    18. Werdan, K
      Supplemental immune globulins in sepsis

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    19. Fraunberger, P; Schaefer, S; Werdan, K; Walli, AK; Seidel, D
      Reduction of circulating cholesterol and apolipoprotein levels during sepsis

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    20. Werdan, K
      The overall concept: Immunoglobulins as adjuvants for mediastinitis - Doesit make sense?

      EUROPEAN JOURNAL OF SURGERY
    21. Hoffmann, JN; Werdan, K; Hartl, WH; Jochum, M; Faist, E; Inthorn, D
      Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds

      SHOCK
    22. Gellerich, FN; Trumbeckaite, S; Hertel, K; Zierz, S; Muller-Werdan, U; Werdan, K; Redl, H; Schlag, G
      Impaired energy metabolism in hearts of septic baboons: Diminished activities of Complex I and Complex II of the mitochondrial respiratory chain

      SHOCK
    23. Loscher, T; Werdan, K
      Travel medicine

      INTERNIST
    24. Werdan, K
      Emergency treatment of acute heart failure

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    25. Loppnow, H; Werdan, K; Reuter, G; Flad, HD
      The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system

      EUROPEAN CYTOKINE NETWORK
    26. Muller-Werdan, U; Engelmann, H; Werdan, K
      Cardiodepression by tumor necrosis factor-alpha

      EUROPEAN CYTOKINE NETWORK
    27. FRAUNBERGER P; PILZ G; CREMER P; WERDAN K; WALLI AK
      ASSOCIATION OF SERUM TUMOR-NECROSIS-FACTOR LEVELS WITH DECREASE OF CHOLESTEROL DURING SEPTIC SHOCK

      Shock (Augusta, Ga.)
    28. WERDAN K
      THE ACTIVATED IMMUNE-SYSTEM IN CONGESTIVE-HEART-FAILURE FROM DROPSY TO THE CYTOKINE PARADIGM

      Journal of internal medicine
    29. WERNER C; LOPPNOW H; WERDAN K; PONICKE K; BRODDE OE
      ALTERED LYMPHOCYTE FUNCTION IN CHRONIC HEART-FAILURE - EFFECTS OF BETA(1)-BLOCKERS

      Naunyn-Schmiedeberg's archives of pharmacology
    30. WERNER C; LOPPNOW H; WERDAN K; PONICKE K; BRODDE OE
      ALTERED LYMPHOCYTE FUNCTION IN CHRONIC HEART-FAILURE - EFFECTS OF BETA(1)-BLOCKERS

      Naunyn-Schmiedeberg's archives of pharmacology
    31. MULLERWERDAN U; SCHUMANN H; LOPPNOW H; FUCHS R; DARMER D; STADLER J; HOLTZ J; WERDAN K
      ENDOTOXIN AND TUMOR-NECROSIS-FACTOR-ALPHA EXERT A SIMILAR PROINFLAMMATORY EFFECT IN NEONATAL RAT CARDIOMYOCYTES, BUT HAVE DIFFERENT CARDIODEPRESSANT PROFILES

      Journal of Molecular and Cellular Cardiology
    32. WERDAN K; SCHUSTER HP
      ORGAN FAILURE IN INTENSIVE-CARE MEDICINE

      Der Internist
    33. WITTHAUT R; WERDAN K; SCHUSTER HP
      MULTIPLE ORGAN DYSFUNCTION AND MULTIPLE O RGAN FAILURE - DIAGNOSIS, PROGNOSIS AND TREATMENT CONCEPTS

      Der Internist
    34. PILZ G; WERDAN K
      SCORES FOR MULTIPLE ORGAN DYSFUNCTION AND FAILURE

      Der Internist
    35. SCHUSTER HP; WERDAN K
      PRECLINICAL EMERGENCY-MEDICINE

      Der Internist
    36. LOPPNOW H; BIL R; HIRT S; SCHONBECK U; HERZBERG M; WERDAN K; RIETSCHEL ET; BRANDT E; FLAD HD
      PLATELET-DERIVED INTERLEUKIN-1 INDUCES CYTOKINE PRODUCTION, BUT NOT PROLIFERATION OF HUMAN VASCULAR SMOOTH-MUSCLE CELLS

      Blood
    37. MULLERWERDAN U; WERDAN K
      ANAPHYLACTIC SHOCK - REPLY

      Anaesthesist
    38. WERDAN UM; WERDAN K
      ANAPHYLACTIC SHOCK

      Anaesthesist
    39. WERDAN K
      CYTOKINES AND HEART-DISEASES - AN ATTEMPT OF AN UPDATE

      Medizinische Klinik
    40. ZELL R; GECK P; WERDAN K; BOEKSTEGERS P
      TNF-ALPHA AND IL-1-ALPHA INHIBIT BOTH PYRUVATE-DEHYDROGENASE ACTIVITYAND MITOCHONDRIAL-FUNCTION IN CARDIOMYOCYTES - EVIDENCE FOR PRIMARY IMPAIRMENT OF MITOCHONDRIAL-FUNCTION

      Molecular and cellular biochemistry
    41. WAIDELICH R; JANSEN HM; STIEBER P; SCHMELLER N; LAMERZ R; WERDAN K; FATEHMOGHADAM A
      SCREENING FOR PROSTATIC-CARCINOMA WITH PROSTATE-SPECIFIC ANTIGEN

      Anticancer research
    42. SCHLEE H; PRONDZINSKY R; OSTEN B; WERDAN K
      SYSTEMIC INFLAMMATORY RESPONSES TO EXTRAC ORPOREAL MEASURES .1. HEMODIALYSIS AND HEMOFILTRATION

      Wiener Klinische Wochenschrift
    43. PRONDZINSKY R; MULLERWERDAN U; PILZ G; WITTHAUT R; STABENOW I; WERDAN K; ZERKOWSKI HR
      SYSTEMIC INFLAMMATORY RESPONSES TO EXTRAC ORPOREAL THERAPEUTIC MEASURES .2. CARDIOPULMONARY BYPASS

      Wiener Klinische Wochenschrift
    44. MULLERWERDAN U; PRONDZINSKY R; WITTHAUT R; STACHE N; HEINROTH K; KUHN C; SCHMIDT H; BUSCH I; WERDAN K
      THE HEART IN SEPSIS AND MODS

      Wiener Klinische Wochenschrift
    45. MULLERWERDAN U; PFEIFER A; HUBNER G; SELIGER C; REITHMANN C; RUPP H; WERDAN K
      PARTIAL INHIBITION OF PROTEIN-SYNTHESIS BY PSEUDOMONAS EXOTOXIN-A DERANGES CATECHOLAMINE SENSITIVITY OF CULTURED RAT-HEART MYOCYTES

      Journal of Molecular and Cellular Cardiology
    46. MULLERWERDAN U; SCHUMANN H; FUCHS R; REITHMANN C; LOPPNOW H; KOCH S; ZIMNYARNDT U; HE C; DARMER D; JUNGBLUT P; STADLER J; HOLTZ J; WERDAN K
      TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IS CARDIODEPRESSANT IN PATHOPHYSIOLOGICALLY RELEVANT CONCENTRATIONS WITHOUT INDUCING INDUCIBLE NITRIC OXIDE-(NO)-SYNTHASE (INOS) OR TRIGGERING SERIOUS CYTOTOXICITY

      Journal of Molecular and Cellular Cardiology
    47. REITHMANN C; REBER D; KOZLIKFELDMANN R; NETZ H; PILZ G; WELZ A; WERDAN K
      A POSTRECEPTOR DEFECT OF ADENYLYL-CYCLASE IN SEVERELY FAILING MYOCARDIUM FROM CHILDREN WITH CONGENITAL HEART-DISEASE

      European journal of pharmacology
    48. PILZ G; APPEL R; KREUZER E; WERDAN K
      COMPARISON OF EARLY IGM-ENRICHED IMMUNOGLOBULIN VS POLYVALENT IGG ADMINISTRATION IN SCORE-IDENTIFIED POSTCARDIAC SURGICAL PATIENTS AT HIGH-RISK FOR SEPSIS

      Chest
    49. WARNER C; MARKAU S; WERDAN K; BRODDE OE
      ALTERATIONS OF IMMUNE FUNCTION IN CONGESTIVE-HEART-FAILURE - CAUSED BY INCREASED SYMPATHETIC ACTIVITY AND PREVENTION BY BETA(1)-BLOCKERS

      Circulation
    50. MULLERWERDAN U; WERDAN K
      ANAPHYLACTIC SHOCK

      Anasthesist
    51. SALAT C; BOEKSTEGERS P; HOLLER E; WERDAN K; REINHARDT B; FATEHMOGHADAM S; PIHUSCH R; KAUL M; BEINERT T; HILLER E
      HEMOSTATIC PARAMETERS IN SEPSIS PATIENTS TREATED WITH ANTI-TNF-ALPHA-MONOCLONAL ANTIBODIES

      Shock
    52. WERDAN K
      FOREWORD

      Infusionstherapie und Transfusionsmedizin
    53. PILZ G; FRAUNBERGER P; APPEL R; KREUZER E; WERDAN K; WALLI A; SEIDEL D
      SIGNIFICANCE OF INCREASED TNF RECEPTOR LE VELS IN HIGHRISK HEART-SURGERY PATIENTS

      Infusionstherapie und Transfusionsmedizin
    54. WERDAN K; PILZ G
      USE OF IMMUNOGLOBULINS IN SEPSIS - A STAT US-REPORT

      Infusionstherapie und Transfusionsmedizin
    55. WITTHAUT R; WERDAN K
      OUTCOME RESEARCH - SIGNIFICANCE FOR SEPSI S AND SEPTIC SHOCK

      Infusionstherapie und Transfusionsmedizin
    56. WERDAN K; MULLERWERDAN U
      ELUCIDATING MOLECULAR MECHANISMS OF SEPTIC CARDIOMYOPATHY - THE CARDIOMYOCYTE MODEL

      Molecular and cellular biochemistry
    57. MULLERWERDAN U; KOIDL B; AUTENRIETH A; KLEIN D; WERDAN K; HAMMER C
      XENOREACTIVE NATURAL ANTIBODIES AND INDUCED ANTIBODIES - THEIR EFFECTS ON BEATING CARDIOMYOCYTES AS A MODEL OF A XENOGRAFT

      Molecular and cellular biochemistry
    58. BOEKSTEGERS P; KAINZ I; GIEHRL W; PETER W; WERDAN K
      SUBCHRONIC EXPOSURE OF CARDIOMYOCYTES TO LOW CONCENTRATIONS OF TUMOR-NECROSIS-FACTOR-ALPHA ATTENUATES THE POSITIVE INOTROPIC RESPONSE NOT ONLY TO CATECHOLAMINES BUT ALSO TO CARDIAC-GLYCOSIDES AND HIGH-CALCIUM CONCENTRATIONS

      Molecular and cellular biochemistry
    59. REITHMANN C; VONSCHEIDT W; WERDAN K
      BETA-ADRENOCEPTOR DESENSITIZATION DESPITE CARDIAC DENERVATION IN HUMAN FAILING TRANSPLANTED MYOCARDIUM

      International journal of cardiology
    60. PILZ G; FRAUNBERGER P; APPEL R; KREUZER E; WERDAN K; WALLI A; SEIDEL D
      EARLY PREDICTION OF OUTCOME IN SCORE-IDENTIFIED, POSTCARDIAC SURGICALPATIENTS AT HIGH-RISK FOR SEPSIS, USING SOLUBLE TUMOR-NECROSIS-FACTORRECEPTOR-P55 CONCENTRATIONS

      Critical care medicine
    61. AUTENRIETH A; MULLERWERDAN U; KOIDL B; WERDAN K; HAMMER C
      DIFFERENT ACTION OF XENOREACTIVE NATURAL AND IMMUNE ANTIBODIES ON FUNCTIONING CARDIOMYOCYTES

      Transplantation proceedings
    62. REITHMANN C; SCHEININGER C; BULGAN T; WERDAN K
      EXPOSURE TO THE N-3 POLYUNSATURATED FATTY-ACID DOCOSAHEXAENOIC ACID IMPAIRS ALPHA(1)-ADRENOCEPTOR-MEDIATED CONTRACTILE RESPONSES AND INOSITOL PHOSPHATE FORMATION IN RAT CARDIOMYOCYTES

      Naunyn-Schmiedeberg's archives of pharmacology
    63. WITTHAUT R; WERDAN K
      OUTCOME RESEARCH AND SEPSIS

      Der Internist
    64. KASEL AM; FAUSSNER A; PFEIFER A; MULLER U; WERDAN K; ROSCHER AA
      B-2 BRADYKININ RECEPTORS IN CULTURED NEONATAL RAT CARDIOMYOCYTES MEDIATE A NEGATIVE CHRONOTROPIC AND NEGATIVE INOTROPIC RESPONSE

      Diabetes
    65. WERDAN K; PILZ G
      SUPPLEMENTAL IMMUNE GLOBULINS IN SEPSIS - A CRITICAL-APPRAISAL

      Clinical and experimental immunology
    66. BAURIEDEL G; SCHLUCKEBIER S; WELSCH U; WERDAN K; HOFLING B
      DISLOCATION OF THE ROTATING CUTTER DURING DIRECTIONAL CORONARY ATHERECTOMY - A NOTE OF CAUTION

      Catheterization and cardiovascular diagnosis
    67. MULLERWERDAN U; KOIDL B; AUTENRIETH A; KLEIN D; ZANDER M; WERDAN K; HAMMER C
      PREFORMED NATURAL ANTIBODIES - THEIR IMPACT ON CONTRACTILE ACTIVITY OF CARDIOMYOCYTES

      Transplantation proceedings
    68. REITHMANN C; WERDAN K
      CHRONIC MUSCARINIC CHOLINOCEPTOR STIMULATION INCREASES ADENYLYL-CYCLASE RESPONSIVENESS IN RAT CARDIOMYOCYTES BY A DECREASE IN THE LEVEL OF INHIBITORY G-PROTEIN ALPHA-SUBUNITS

      Naunyn-Schmiedeberg's archives of pharmacology
    69. ARENDT RM; SCHMOECKEL M; WILBERTLAMPEN U; PLASSE A; HEUCKE L; WERDAN K
      BIDIRECTIONAL EFFECTS OF ENDOGENOUS OPIOID-PEPTIDES ON ENDOTHELIN RELEASE RATES IN PORCINE AORTIC ENDOTHELIAL-CELL CULTURE - MEDIATION BY DELTA-OPIOID RECEPTOR AND OPIOID RECEPTOR ANTAGONIST-INSENSITIVE MECHANISMS

      The Journal of pharmacology and experimental therapeutics
    70. VOGELMEIER C; MULLERWERDAN U; WERDAN K
      CIRCULATORY SHOCK - EXTRAPULMONARY ORIGIN OF RESPIRATORY-DISTRESS SYNDROME

      Der Internist
    71. GAWAZ M; FATEHMOGHADAM S; PILZ G; GURLAND HJ; WERDAN K
      PLATELET ACTIVATION AND INTERACTION WITH LEUKOCYTES IN PATIENTS WITH SEPSIS OR MULTIPLE ORGAN FAILURE

      European journal of clinical investigation
    72. BAURIEDEL G; SCHWAIBLMAIR M; NABAUER M; HEUCK A; HERTLEIN H; BITTMANN I; NERLICH A; WERDAN K
      SPONTANEOUS HEMOTHORAX IN DERMATOMYOSITIS AND CHRONIC GLUCOCORTICOID TREATMENT

      Deutsche Medizinische Wochenschrift
    73. BAURIEDEL G; SCHWAIBLMAIR M; NABAUER M; WERDAN K; HEUCK A; HERTLEIN H; BITTMANN I; NERLICH A
      SPONTANEOUS HEMOTHORAX IN DERMATOMYOSITIS AND CHRONIC GLUCOCORTICOID TREATMENT - REPLY

      Deutsche Medizinische Wochenschrift
    74. BAURIEDEL G; SCHWAIBLMAIR M; KREUZER E; WERDAN K
      PERCUTANEOUS INTRAAORTIC COUNTERPULSATION AS A THERAPEUTIC OPTION IN CARDIOGENIC-SHOCK

      Deutsche Medizinische Wochenschrift
    75. BOEKSTEGERS P; WEIDENHOFER S; ZELL R; PILZ G; HOLLER E; ERTEL W; KAPSNER T; REDL H; SCHLAG G; KAUL M; KEMPENI J; STENZEL R; WERDAN K
      REPEATED ADMINISTRATION OF A F(AB')2 FRAGMENT OF AN ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY IN PATIENTS WITH SEVERE SEPSIS - EFFECTS ON THE CARDIOVASCULAR-SYSTEM AND CYTOKINE LEVELS

      Shock
    76. BOEKSTEGERS P; WEIDENHOFER S; ZELL R; HOLLER E; KAPSNER T; REDL H; SCHLAG G; KAUL M; KEMPENI J; WERDAN K
      CHANGES IN SKELETAL-MUSCLE PO2 AFTER ADMINISTRATION OF ANTI-TNF-ALPHA-ANTIBODY IN PATIENTS WITH SEVERE SEPSIS - COMPARISON TO INTERLEUKIN-6SERUM LEVELS, APACHE-II, AND ELEBUTE SCORES

      Shock
    77. BOEKSTEGERS P; PETER W; WERDAN K; NIENABER CA
      SYNCHRONIZED CORONARY VENOUS RETROPERFUSION - REPLY

      Journal of the American College of Cardiology
    78. BOEKSTEGERS P; PETER W; VONDEGENFELD G; NIENABER CA; ABEND M; REHDERS TC; HABAZETTL H; KAPSNER T; VONLUDINGHAUSEN M; WERDAN K
      PRESERVATION OF REGIONAL MYOCARDIAL-FUNCTION AND MYOCARDIAL OXYGEN-TENSION DURING ACUTE-ISCHEMIA IN PIGS - COMPARISON OF SELECTIVE SYNCHRONIZED SUCTION AND RETROINFUSION OF CORONARY VEINS TO SYNCHRONIZED CORONARY VENOUS RETROPERFUSION

      Journal of the American College of Cardiology
    79. LINK H; HERRMANN F; WELTE K; AULITZKY WE; GANSER A; KERN WV; MEYER P; SCHRAPPE M; SCHMOLL HJ; WERDAN K; KERN P
      RATIONAL THERAPY WITH G-CSF AND GM-CSF

      Medizinische Klinik
    80. PILZ G; KAAB S; KREUZER E; WERDAN K
      EVALUATION OF DEFINITIONS AND PARAMETERS FOR SEPSIS ASSESSMENT IN PATIENTS AFTER CARDIAC-SURGERY

      Infection
    81. LORENZ W; NEUGEBAUER E; PILZ G; WERDAN K; LORENZ M
      METHODOLOGY OF CLINICAL-TRIALS IN SEPSIS - INTRODUCTION

      Theoretical surgery
    82. PILZ G; MCGINN P; BOEKSTEGERS P; KAAB S; WEIDENHOFER S; WERDAN K
      PSEUDOMONAS SEPSIS DOES NOT CAUSE MORE SEVERE CARDIOVASCULAR DYSFUNCTION IN PATIENTS THAN NON-PSEUDOMONAS SEPSIS

      Circulatory shock
    83. BOEKSTEGERS P; WEIDENHOFER S; KAPSNER T; WERDAN K
      SKELETAL-MUSCLE PARTIAL-PRESSURE OF OXYGEN IN PATIENTS WITH SEPSIS

      Critical care medicine
    84. MULLER U; KLEIN D; ZANDER M; WERDAN K; HAMMER C
      PREFORMED NATURAL ANTIBODIES - THEIR IMPACT ON BEATING NEONATAL RAT CARDIOMYOCYTES

      Transplantation proceedings
    85. MULLERWERDAN U; KLEIN D; ZANDER M; WERDAN K; HAMMER C
      BEATING NEONATAL RAT CARDIOMYOCYTES AS A MODEL TO STUDY THE ROLE OF XENOREACTIVE NATURAL ANTIBODIES IN XENOTRANSPLANTATION

      Transplantation
    86. REITHMANN C; WERDAN K
      TUMOR-NECROSIS-FACTOR-ALPHA DECREASES INOSITOL PHOSPHATE FORMATION AND PHOSPHATIDYLINOSITOL-BISPHOSPHATE (PIP2) SYNTHESIS IN RAT CARDIOMYOCYTES

      Naunyn-Schmiedeberg's archives of pharmacology
    87. PILZ G; WERDAN K; MCGINN P
      EVALUATION OF DEFINITIONS OF SEPSIS

      Chest
    88. PILZ G; KREUZER E; KAAB S; APPEL R; WERDAN K
      EARLY SEPSIS TREATMENT WITH IMMUNOGLOBULINS AFTER CARDIAC-SURGERY IN SCORE-IDENTIFIED HIGH-RISK PATIENTS

      Chest
    89. ARENDT RM; SCHMOECKEL M; WERDAN K
      BIDIRECTIONAL EFFECTS OF OPIOIDS ON ENDOTHELIN RELEASE

      Clinical research
    90. PILZ G; KAAB S; KREUZER E; WERDAN K
      EARLY IDENTIFICATION OF PATIENTS AT RISK FOR SEPSIS FOLLOWING CARDIAC-SURGERY

      Infusionstherapie und Transfusionsmedizin
    91. BOEKSTEGERS P; WEIDENHOFER S; KAPSNER T; WERDAN K
      CONTINUOUS MEASUREMENT OF PERIPHERAL OXYG EN AVAILABILITY IN SKELETAL-MUSCLES OF PATIENTS WITH SEPSIS

      Infusionstherapie und Transfusionsmedizin
    92. PILZ G; KREUZER E; KAAB S; APPEL R; WERDAN K
      EARLY IMMUNOGLOBULIN THERAPY FOR PATIENTS AT RISK FOR SEPSIS FOLLOWING CARDIAC-SURGERY

      Infusionstherapie und Transfusionsmedizin
    93. REITHMANN C; HALLSTROM S; PILZ G; KAPSNER T; SCHLAG G; WERDAN K
      DESENSITIZATION OF RAT CARDIOMYOCYTE ADENYLYL-CYCLASE STIMULATION BY PLASMA OF NORADRENALINE-TREATED PATIENTS WITH SEPTIC SHOCK

      Circulatory shock


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 12:41:42